griseofulvin
Generic: griseofulvin
Labeler: sandoz incDrug Facts
Product Profile
Brand Name
griseofulvin
Generic Name
griseofulvin
Labeler
sandoz inc
Dosage Form
TABLET
Routes
Active Ingredients
griseofulvin 500 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0781-5515
Product ID
0781-5515_79afc7a7-d77e-48eb-b1c6-6ea974801f38
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091592
Listing Expiration
2026-12-31
Marketing Start
2013-08-07
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
07815515
Hyphenated Format
0781-5515
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
griseofulvin (source: ndc)
Generic Name
griseofulvin (source: ndc)
Application Number
ANDA091592 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (0781-5515-01)
- 500 TABLET in 1 BOTTLE (0781-5515-05)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "79afc7a7-d77e-48eb-b1c6-6ea974801f38", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "upc": ["0307815514013"], "unii": ["32HRV3E3D5"], "rxcui": ["239239", "310600"], "spl_set_id": ["98829d90-b289-4bec-a625-7af412a5cb2d"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0781-5515-01)", "package_ndc": "0781-5515-01", "marketing_start_date": "20130807"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (0781-5515-05)", "package_ndc": "0781-5515-05", "marketing_start_date": "20130807"}], "brand_name": "Griseofulvin", "product_id": "0781-5515_79afc7a7-d77e-48eb-b1c6-6ea974801f38", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "0781-5515", "generic_name": "Griseofulvin", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Griseofulvin", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "500 mg/1"}], "application_number": "ANDA091592", "marketing_category": "ANDA", "marketing_start_date": "20130807", "listing_expiration_date": "20261231"}